Abstract:The aim of this study was to discover potent angiotensin-converting enzyme (ACE) inhibitory (ACEI) peptides from Pinctada fucata (P. fucata) for treating hypertension and to characterize them using in silico analysis. The P. fucata proteins were hydrolyzed by Alcalase®, a serine endopeptidase with broad selectivity, at various times (0, 2, 4, 6, 8, 10 h). The degree of hydrolysis (DH) and ACEI activity of the different hydrolysates were measured. Considering the molecular weight and ACEI activity, the 10 h hydrolysate was purified by a series of traditional separation methods, including ultrafiltration, gel G-25 chromatography, and reversed-phase high-performance liquid chromatography (RP-HPLC), with ACEI activity as a guide. The results showed two fractions, C17 and C18, eluted by means of semi-preparative RP-HPLC, and showed the highest ACEI activities of 80.33 ± 2.70% and 81.66 ± 0.29%, respectively, at 1 mg mL-1. The two fractions were then identified using liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) and their MS/MS spectra data were subjected to de novo sequencing. Subsequently, the potential ACEI peptides were screened by in silico methods, namely, to analyze the average local confidence (ALC) value obtained from the sequencing software and the P-value from the Pepsite 2. In total, 13 potential ACEI peptide sequences were obtained and identified from the two fractions by LC-ESI-MS/MS, and two novel tetrapeptides, FRVW (607.3314 Da) and LPYY (555.2881 Da), were screened for synthesis according to the in silico analysis. The in vitro ACEI tests indicated that FRVW and LPYY had IC50 values of 18.34 and 116.26 μM, respectively. The Lineweaver-Burk plot showed that FRVW was a noncompetitive inhibitor, and LPYY was shown to be a mixed-mode type inhibitor. A stability study against ACE indicated that both peptides were hydrolyzed by ACE to some extent, the higher ACEI activity following incubation with ACE indicating that they should be classified as pro-drug substrates. Molecular docking results showed that hydrophobic amino acids (HAAs) within peptides formed vital interactions including hydrogen bonds, electrostatic forces, van der Waals forces and Pi-Pi interactions with ACE residues, which stabilized the enzyme-peptide complex. Furthermore, the docking results accorded with the inhibition kinetic mode. Our study demonstrated that FRVW and LPYY isolated from P. fucata have potential applications as antihypertensive agents.

Purification and Identification of Dipeptidyl Peptidase IV and Angiotensin-Converting Enzyme Inhibitory Peptides from Silver Carp ( Hypophthalmichthys Molitrix ) Muscle Hydrolysate

Production and Identification of Antioxidant and Angiotensin-Converting Enzyme Inhibition and Dipeptidyl Peptidase Iv Inhibitory Peptides from Bighead Carp (hypophthalmichthys Nobilis) Muscle Hydrolysate

Enzyme Hydrolysis and Inhibition of Hydrolysates from Silver Carp Hypophthalmichthys molitrix Meat on Angiotensin Ⅰ - Converting Enzyme (ACE)

Preparation and Purification of Angiotensin-Converting Enzyme Inhibitory Peptides from Hydrolysate of Shrimp (litopenaeus Vannamei) Shell Waste

Dipeptidyl Peptidase IV-Inhibitory Peptides Derived from Silver Carp (hypophthalmichthys Molitrix Val.) Proteins.

Purification and Identification of Novel Dipeptidyl Peptidase IV Inhibitory Peptides Derived from Bighead Carp (hypophthalmichthys Nobilis)

Identification And Characterization Of Dpp-Iv Inhibitory Peptides From Silver Carp Swim Bladder Hydrolysates

Purification and characterization of the dipeptidyl peptidase-IV inhibitory peptides from eel (Anguilla rostrata) scraps enzymatic hydrolysate for the treatment of type 2 diabetes mellitus

Optimization of Hydrolysis Conditions for Preparing ACE Inhibitory Peptides from Silver Carp Hypophthalmichthys molitrix with Flavorzyme

Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate

Purification and Identification of Novel Antioxidant Peptides from Silver Carp Muscle Hydrolysate after Simulated Gastrointestinal Digestion and Transepithelial Transport.

Identification of Bioactive Peptides from a Laminaria digitata Protein Hydrolysate Using In Silico and In Vitro Methods to Identify Angiotensin-1-Converting Enzyme (ACE-1) Inhibitory Peptides

Extraction,purification and properties of a serine proteinase inhibitor from silver carp(Hypophthalmichthys molitrix) skeletal muscle

Grass Carp Peptides Hydrolysed By The Combination Of Alcalase And Neutrase: Angiotensin-I Converting Enzyme (Ace) Inhibitory Activity, Antioxidant Activities And Physicochemical Profiles

Evaluating in vitro dipeptidyl peptidase IV inhibition by peptides from common carp ( Cyprinus carpio ) roe in cell culture models

Two novel potent ACEI peptides isolated from Pinctada fucata meat hydrolysates using in silico analysis: identification, screening and inhibitory mechanisms

Purification and identification of Angiotensin-I Converting Enzyme (ACE) inhibitory peptide from lizard fish (Saurida elongata) hydrolysate

Effects of high hydrostatic pressure treatment: Identification and characterization of snakehead-muscle-protein-based angiotensin-converting-enzyme-inhibitory peptides

Purification and identification of antioxidant peptides from grass carp muscle hydrolysates by consecutive chromatography and electrospray ionization-mass spectrometry

Purification and characterization of a novel angiotensin I-converting enzyme-inhibitory peptide derived from Alaska pollack skins

Purification, identification and molecular mechanism of dipeptidyl peptidase IV inhibitory peptides from discarded shrimp (Penaeus vannamei) head